Highland, D. O., & Gahlemann, M. (2019). Nintedanib for Systemic Sclerosis- Associated Interstitial Lung Disease. New England Journal of Medicine, 380(26), 2592. https://doi.org/10.1056/NEJMoal903076
Chicago Style (17th ed.) CitationHighland, Distler O., and M. Gahlemann. "Nintedanib for Systemic Sclerosis- Associated Interstitial Lung Disease." New England Journal of Medicine 380, no. 26 (2019): 2592. https://doi.org/10.1056/NEJMoal903076.
MLA (9th ed.) CitationHighland, Distler O., and M. Gahlemann. "Nintedanib for Systemic Sclerosis- Associated Interstitial Lung Disease." New England Journal of Medicine, vol. 380, no. 26, 2019, p. 2592, https://doi.org/10.1056/NEJMoal903076.
Warning: These citations may not always be 100% accurate.